Placebo + ADUCANUMAB

2 treatments and conditions followed through the public trial records. Not medical advice. How a status is set

Treatments and conditions

Placebo + ADUCANUMAB
Treatment and conditionWhere it standsTrials
Placebo + ADUCANUMAB for alzheimer diseasePhase 1 trial, as of 19 Nov 2026 (not yet checked by a person)4
Placebo + ADUCANUMAB for cognitive dysfunctionTrials ended early, as of 19 Nov 2026 (not yet checked by a person)1